AngioWaveNet vs Ligence Heart
AI Verdict
Choose AngioWaveNet if…
Choose AngioWaveNet if your cardiac catheterization lab frequently performs fluoroscopic angiograms and requires superior real-time vessel visualization. This tool is ideal for enhancing the clarity of blood vessels and anatomical features during interventional procedures, integrating seamlessly with your existing cath lab workflow to improve diagnostic and procedural confidence.
View AngioWaveNet →Choose Ligence Heart if…
Choose Ligence Heart if your cardiology department aims to automate and standardize the analysis and reporting of 2D transthoracic echocardiograms. This platform is best suited for reducing manual measurement time, improving diagnostic efficiency, and ensuring consistent, accurate reporting across a broad spectrum of cardiac conditions, including heart failure and valvular diseases.
View Ligence Heart →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AngioWaveNet | Ligence Heart |
|---|---|---|
| Pricing | Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available. | Contact-for-pricing |
| Deployment | Cloud-based or on-premise/servers | Cloud-based; on-premise; hybrid |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Ligence HeartLigence Heart is a web-based, out-of-the-box platform designed to automate echocardiography analysis and reporting, aiming to reduce multitasking and streamline workflow for clinicians. Its interface is designed to be intuitive and familiar, with training videos provided. AngioWaveNet integrates seamlessly into existing Cath lab workflows as a post-processing AI, offering side-by-side viewing and requiring minimal training.
Clinical Value
Ligence HeartBoth tools are FDA-cleared and offer significant clinical benefits. Ligence Heart has multiple validated studies demonstrating non-inferior or superior accuracy compared to human experts for various echocardiographic measurements, significantly enhancing diagnostic efficiency and consistency, including disease recognition. AngioWaveNet improves vessel visualization in fluoroscopic angiograms, acting as a valuable complement to standard imaging for real-time decision-making.
Pricing & Value
AngioWaveNetAngioWaveNet offers more transparent pricing models, including annual software licensing or subscription-based access tailored to cath lab volume and hospital needs, with custom packages available. Ligence Heart's pricing requires direct contact, offering less upfront transparency, although its automation capabilities promise significant time savings and increased patient throughput.
Enterprise Readiness
Ligence HeartBoth are FDA-cleared, HIPAA compliant, and offer flexible deployment. Ligence Heart explicitly states it has a Business Associate Agreement (BAA) and details robust IT security measures in its Instructions for Use, alongside comprehensive integration with PACS, EHR, and RIS, and options for custom API solutions. AngioWaveNet also demonstrates strong security and vendor-agnostic DICOM integration.
Innovation
Ligence HeartLigence Heart's comprehensive automation of complex echocardiography analysis, including advanced measurements and disease recognition, and its documented ability to surpass human performance in specific metrics, represents a profound innovation in diagnostic efficiency and accuracy. AngioWaveNet's AI-powered Spatiotemporal Enhancement Processing (STEPu2122) for real-time image enhancement during live procedures is also highly innovative, improving immediate clinical decision-making.
Support & Docs
Ligence HeartLigence Heart provides comprehensive support resources, including training videos, detailed Instructions for Use (IFU) available online in multiple languages, and direct contact information for customer support and security. AngioWaveNet mentions minimal training and an intuitive design but lacks specific details on documentation or dedicated support channels beyond general contact information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AngioWaveNet | Ligence Heart |
|---|---|---|
| Primary Function | FDA-cleared AI software that enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories, integrating with existing Cath lab workflows. | AI-powered web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency and accuracy for cardiologists and sonographers. |
| Target Specialties | Cardiology, Interventional Radiology, Vascular Surgery | Cardiology |
| Core Technology/Methodology | AI-powered Spatiotemporal Enhancement Processing (STEPu2122); Improved vessel visualization in fluoroscopic angiograms; Post-processing AI for angiographic images. | Automated recognition of echocardiography imaging data; Automated view classification and heart phase prediction; Automated calculation of measurements and report generation. |
| Integration Capabilities | Integrates with existing Cath lab workflows; Functions as a DICOM endpoint for imaging systems. | Integration with existing systems (PACS, EHR, RIS); Transfer of echocardiography images (PHI removed) from hospital PACS. |
Videos
Demos, reviews, and walkthroughs featuring AngioWaveNet and Ligence Heart.